Recruitment

Recruitment Status
Completed
Estimated Enrollment
20

Inclusion Criteria

Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs
Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs

Exclusion Criteria

Pregnancy, drug abuse
Carotid artery stenosis > 70%
Treatment with other extracorporeal devices
...
Pregnancy, drug abuse
Carotid artery stenosis > 70%
Treatment with other extracorporeal devices
Allergy against materials of the medical device used in the study (transcranial Doppler) or temporal skin/bone lesions
Neurocognitive disturbances
Patent foramen ovale
Inclusion in an other clinical study
Absent informed consent
Cardial pathology (valvular heart disease, prosthesis, endocarditis)
Preexistent neurological morbidity

Summary

Conditions
  • Cerebral Embolism
  • Complication of Dialysis
  • Thrombus Due to Renal Dialysis Device, Implant, or Graft
Type
Observational
Design
  • Observational Model: Case-Only
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 90 years
Gender
Both males and females

Inclusion Criteria

Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs
Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs

Exclusion Criteria

Pregnancy, drug abuse
Carotid artery stenosis > 70%
Treatment with other extracorporeal devices
...
Pregnancy, drug abuse
Carotid artery stenosis > 70%
Treatment with other extracorporeal devices
Allergy against materials of the medical device used in the study (transcranial Doppler) or temporal skin/bone lesions
Neurocognitive disturbances
Patent foramen ovale
Inclusion in an other clinical study
Absent informed consent
Cardial pathology (valvular heart disease, prosthesis, endocarditis)
Preexistent neurological morbidity

Tracking Information

NCT #
NCT02021045
Collaborators
Not Provided
Investigators
  • Principal Investigator: Gabor Erdoes, MD Medical University of Vienna
  • Gabor Erdoes, MD Medical University of Vienna